Searched for
IMMUNOLOGY PRODUCTS
Biocon gets Health Canada nod for Yesintek autoinjector penBiocon received Health Canada approval for its Yesintek autoinjector. This new format offers patients a convenient treatment option for pso...- 10,000-year-old disease that haunted Greeks and Chinese, weakened Civil War soldiers and caused 5% of 20th century deaths may finally have a weakness; Indian researchers find breakthroughScientists from India and Britain have identified a protein called Ark1 that acts as a control switch in the malaria parasite's cell divisi...
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%, according to analystsThis is easy to say, but difficult to actually implement: As an investor, make a distinction between the day-to-day movement of indices and...
- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Veterinary vaccine firms form association for collaboration with policymakersIndia's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have formed the Veterinary Vaccin...
- Hester Biosciences to roll out Covaxin drug substance by April 2022Ahmedabad-based Hester Biosciences is a part of Gujarat Covid Vaccine Consortium (GCVC), which in May this year signed an agreement with Bh...
- Monthly production capacity of Covishield, Covaxin planned to be increased: GovtFrom January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...
- Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: MinisterUnion Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...
- State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...
- Bharat Biotech raises Covaxin capacity by another 200 million doses a year“The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
- Govt aims for 6-7 crore Covaxin doses/month by July-AugustThe state-run Public Sector Undertaking (PSUs) will manufacture the drug on the basis of transfer of technology. “The government of India w...
- IIL set to expand its protozoan Vaccine portfolioInstituto Nacional de Tecnologia Agropecuaria (INTA) is Argentina’s federal agency in charge of the generation, adaptation and diffusion of...
- Indian Immunologicals to unveil feed for lab animals used for clinical trialsAt present, India houses hundreds of scientific bodies, both in public and private sectors, which together have nearly 10 million lab anima...
- Indian Immunologicals plans Rs 300 crore vaccine plant in PondicherryHyderabad headquartered vaccine manufacturer Indian Immunologicals Ltd (IIL), part of the National Dairy Development Board, is setting up a...
Load More
